XML 34 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Other Liabilities
3 Months Ended
Mar. 31, 2018
Other Liabilities Disclosure [Abstract]  
Other Liabilities
Note 12 – Other Liabilities
 
March 31, 2018
 
December 31, 2017
Contingent loan repurchase liability
$
347,081

 
$
431,492

Other accrued expenses
59,683

 
75,088

Accrued legal fees and settlements
46,305

 
51,057

Due to NRZ
38,516

 
98,493

Servicing-related obligations
33,653

 
35,239

Liability for indemnification obligations
21,336

 
23,117

Checks held for escheat
20,846

 
19,306

Accrued interest payable
13,183

 
5,172

Deferred revenue
3,910

 
3,463

Amounts due in connection with MSR sales
3,716

 
8,291

Liability for uncertain tax positions
3,322

 
3,252

Derivatives, at fair value
2,169

 
635

Other
14,731

 
14,805

 
$
608,451

 
$
769,410


We monitor our legal and regulatory matters, including advice from external legal counsel, and periodically perform assessments of these matters for potential loss accrual and disclosure. We establish a liability for settlements, including fines and penalties, judgments on appeal and filed and/or threatened claims for which we believe it is probable that a loss has been or will be incurred and the amount can be reasonably estimated. See Note 18 – Regulatory Requirements and Note 20 – Contingencies for additional information.
Accrued Legal Fees and Settlements
Three Months Ended March 31,
2018
 
2017
Beginning balance
$
51,057

 
$
93,797

Accrual for probable losses (1)
7,452

 
13,293

Payments (2)
(6,036
)
 
(25,860
)
Issuance of common stock in settlement of litigation (3)
(5,719
)
 

Net change in accrued legal fees
(299
)
 
807

Other
(150
)
 

Ending balance
$
46,305

 
$
82,037

(1)
Consists of amounts accrued for probable losses in connection with legal and regulatory settlements and judgments. Such amounts are reported in Professional services expense in the unaudited consolidated statements of operations.
(2)
Includes cash payments made in connection with resolved legal and regulatory matters.
(3)
In January 2018, Ocwen issued 1,875,000 shares of common stock in connection with a previously approved securities litigation settlement.